Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study

por Pakdaman, Hossein, Gharagozli, Koroush, Abbasi, Mehdi, Sobhanian, Ali, Bakhshandehpour, Ali, Ashrafi, Farzad, Khalilzad, Mitra, Amini Harandi, Ali
Publicado 2018

MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study

por Pakdaman, Hossein, Gharagozli, Koroush, Karamiani, Faezeh, Shamsi Goushki, Maryam, Moini, Saman, Sobhanian, Ali, Maghsoudlu, Faeze, Esfandani, Akram, Hosseini, Mohammad Hossein, Amini Harandi, Ali
Publicado 2023

Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial

por Barati, Saghar, MohammadReza Hashemian, Seyed, Tabarsi, Payam, Abedini, Atefeh, Ashrafzadeh, Mahshid, Haseli, Sara, Abtahian, Zahra, Yousefian, Sahar, Dastan, Alireza, Sobhanian, Ali, Dastan, Farzaneh
Publicado 2021